Europe Cell Based Assay Market

Europe Cell-Based Assay Market Size (2022 to 2027)

The size of the Cell-Based Assay Market in Europe was worth USD 4.47 billion in 2022 and is estimated to be growing at a CAGR of 10.84% to reach USD 7.47 billion by 2027. Europe is the second-largest cell-based assay market.

The rising incidence of chronic cases, growing demand for cell-based assays are majorly driving growth for the European cell-based assay market. Additionally, increasing R & D activities towards the innovations to battle against deadly diseases such as cancer, cardiovascular diseases, and others are estimated to add fuel to the market's growth rate in Europe. Wide usage of these cell-based assays in applications such as diagnostics and pathology, rise in funds by government and other private sectors for R&D are predicted to favor the European market during the forecast period. Furthermore, growing awareness related to the applications of cell-based assays is a positive sign.

Lack of experienced professionals is to hinder the cell-based assay market growth during the analysis period. Also, the high cost of the instruments and strict regulatory recommendations may hamper the growth. Moreover, boundaries on reagent use may also obstruct the market.

This research report on the Europe Cell-Based Assay Market has been segmented and sub-segmented into the following categories:

By Type Of Product: 

• Cell Lines
  • Primary Cell Lines
  • Stem Cell Lines
  • Immortalized Cell Lines
• Assay Ready Kits
• Cell Culture Kits
• Reagents & Consumables
• Ligands & Inhibitors

By Technology: 

• Automated Handling
• Flow Cytometry
• Label-Free Detection
• High Content Screening

By Application: 

• Drug Discovery
• ADME Research

By End Users: 

• Academia
• Biotechnology
• Pharmaceuticals
• CRO

By Country: 

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Regionally, Spain and Italy are the fastest emerging markets in the European region for the cell-based assay market. An increase in the adoption of cell-based assays platforms and enormous biotechnology and pharmaceutical companies in the area augment market growth. Advance technologies in activities like improved systems, innovative and disposable columns, better-performing resins, and alternative accessories square measures help the cell-based assays market grow considerably. Growing expenditure by the government sector to lessen the death rates from cancer is responsible for market growth.

Noteworthy companies leading the European Cell-Based Assay Market profiled in this report are Thermo Fisher Scientific Inc., Becton & Dickinson and Company, Merck & Co. Inc., Cell Signalling Technology Inc., PerkinElmer Inc., Danaher Corporation, General Electric Company, Cisbio Bioassays, DiscoveRx, Ametek Inc., Bio-Rad Laboratories, Roche Diagnostics, GE Healthcare, and Promega Corporation.